Stay updated on Pembrolizumab for Leukoplakia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Leukoplakia Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2; the page still shows a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-18T02:15:16.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error screen.
    Difference
    0.2%
    Check dated 2026-10-11T03:23:49.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Access to the study record is blocked, with the page now displaying a 403 Forbidden error instead of the study details. The error page includes the typical site header and footer.
    Difference
    18%
    Check dated 2026-09-20T01:12:08.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    Revision: v3.6.6 replaces v3.6.5 as the page's revision label. This indicates a small, behind-the-scenes update to the site version without visible changes to content or functionality.
    Difference
    0.1%
    Check dated 2026-08-29T19:58:44.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    August 2026 dates were added to the Study Record Dates and older July dates were removed, reflecting an update to the revision history for NCT03603223.
    Difference
    0.2%
    Check dated 2026-08-22T21:46:49.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.6.4 to v3.6.5, indicating a minor site update. No changes to study content or user actions.
    Difference
    0.1%
    Check dated 2026-08-08T19:44:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Leukoplakia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Leukoplakia Clinical Trial page.